Lyra Therapeutics Shares Rise on Phase 2 Study Success

cafead

Administrator
Staff member
  • cafead   Sep 12, 2023 at 07:22: PM
via Lyra Therapeutics shares moved higher in premarket trading Tuesday after the clinical-stage biotechnology company reported a successful Phase 2 study of its LYR-220 drug candidate in the inflammatory sinus disease chronic rhinosinusitis.

article source
 

<